Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
53 studies found for:    Open Studies | "Eosinophilia"
Show Display Options
Rank Status Study
1 Recruiting Collection of Peripheral Blood and Bone Marrow From Healthy Donors for Use in In Vitro Research
Condition: Eosinophilia
Intervention:
2 Recruiting Functional Dyspepsia (FD) - Clinical Response to Montelukast in Children
Conditions: Eosinophilia;   Dyspepsia
Intervention:
3 Recruiting Eosinophilia Diagnosis
Condition: Hypereosinophilic Syndrome
Intervention: Other: Scheduled exams and diagnosis
4 Recruiting Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Conditions: Asthma;   Eosinophilia;   Helminthiasis;   Hypersensitivity;   Parasitic Disease
Intervention:
5 Recruiting Comparison Between Corticosteroid and Topical Steroids in the DRESS
Condition: Drug Rash With Eosinophilia and Systemic Symptoms
Interventions: Drug: Prednisone;   Drug: Clobetasol
6 Recruiting Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index
Conditions: Deglutition Disorders;   Esophageal Diseases;   Eosinophilia
Intervention: Other: assessment of disease activity using the EEsAI
7 Recruiting Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders
Conditions: Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease;   Food Allergy
Intervention:
8 Recruiting Imatinib Mesylate to Treat Myeloproliferative Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Intervention: Drug: Imatinib Mesylate
9 Recruiting Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Interventions: Drug: benralizumab;   Other: Placebo
10 Not yet recruiting Trial of Ketotifen in Children and Adolescents
Condition: Functional Dyspepsia
Interventions: Drug: Ketotifen;   Drug: Placebo
11 Recruiting Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients
Condition: Asthma
Interventions: Biological: Mepolizumab 100mg;   Drug: Placebo
12 Recruiting A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression
Condition: Familial Hypereosinophilia
Intervention:
13 Recruiting Severe Cutaneous Adverse Reactions in Thailand
Conditions: Steven-Johnson Syndrome;   Toxic Epidermal Necrolysis;   Drug Reaction With Eosinophilia and Systemic Symptoms;   Acute Generalized Exanthematous Pustulosis;   Generalized Bullous Fixed Drug Eruption
Intervention:
14 Recruiting SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia)
Conditions: Myelofibrosis;   Chronic Myelomonocytic Leukemia;   Advanced Systemic Mastocytosis;   Advanced Symptomatic Primary Eosinophilic Disorder
Intervention: Drug: SL-401
15 Recruiting Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Intervention: Drug: Dexpramipexole
16 Recruiting Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma
Condition: Severe Eosinophilic Asthma
Interventions: Drug: OC000459;   Drug: Placebo
17 Recruiting European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank
Conditions: Lung Diseases, Interstitial;   Pulmonary Alveolar Proteinosis;   Pulmonary Eosinophilia;   Pulmonary Fibrosis;   Respiratory Distress Syndrome, Newborn;   Child
Intervention:
18 Recruiting Steroid Treatment for Hypereosinophilic Syndrome
Condition: Hypereosinophilia
Intervention: Drug: Corticosteroids
19 Not yet recruiting Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
Condition: Hypereosinophilic Syndrome
Interventions: Drug: Mepolizumab 300 mg;   Drug: Placebo matching mepolizumab;   Drug: Active OCS capsules (5 mg prednisolone or prednisone);   Drug: Placebo matching OCS capsules
20 Recruiting Compassionate Use of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES)
Condition: Hypereosinophilic Syndrome
Intervention: Drug: mepolizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.